Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer

作者
Guoxiu Wang,Jiuda Zhao,Yan Song,Wen Zhang,Yongkun Sun,Aiping Zhou,Jing Huang,Feng Du,Lin Yang
出处
期刊:BMC Cancer [BioMed Central]
卷期号:18 (1): 547-547 被引量:18
标识
DOI:10.1186/s12885-018-4480-9
摘要

BACKGROUND: S-1 plus oxaliplatin(SOX) has been demonstrated to be effective and well tolerated for patients with metastatic gastric cancer. We conducted this phase II study to evaluate the feasibility of SOX as adjuvant chemotherapy for gastric cancer after curative resection. METHODS: daily from day 1 to 14 of a 3-week cycle. A total of 58 patients were enrolled in this study. The primary end point of the trial was the treatment completion rate for six cycles. Secondary endpoints were safety, 1-year and 3-year of disease free survival (DFS) and overall survival (OS). RESULTS: A total of 58 patients were enrolled and 54 patients have been analysed. The completion rate of six cycles was 72.2%. Grade 4 toxicities included neutropenia (1.9%) and thrombocytopenia (3.7%). Grade 3 toxicities included leukopenia (5.6%), neutropenia (24.1%), thrombocytopenia (13.0%), nausea (7.4%), vomiting 13.0%), and diarrhea (13.0%). There was no grade 3 or higher peripheral sensory neuropathy and treatment-related death. The median follow-up time was 42.4 months. 1-year and 3-year DFS rate were 85.2 and 75.9%, respectively.1-year and 3-year OS were 98.1 and 85.2%, respectively. CONCLUSION: Adjuvant chemotherapy for GC with S-1 plus oxaliplatin is safe and feasible in Chinese patients. The optimal dose of oxaliplatin and optimal cycles of treatment still need to be further investigated. TRIAL REGISTRATION: clinicaltrials.gov identifier NCT01542294 . Trial registration date: 03/02/2012.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
聪明香之完成签到,获得积分10
刚刚
刚刚
ly1完成签到 ,获得积分10
1秒前
1秒前
疯狂的似狮完成签到,获得积分10
2秒前
感性的剑愁完成签到,获得积分10
2秒前
Limerence完成签到,获得积分10
2秒前
蓝天完成签到,获得积分10
3秒前
卡卡滴滴发布了新的文献求助10
3秒前
鲤鱼新竹完成签到,获得积分10
3秒前
马胤博完成签到,获得积分10
3秒前
赵Zhao完成签到,获得积分10
3秒前
4秒前
星空完成签到,获得积分10
4秒前
4秒前
戴维少尉完成签到,获得积分0
4秒前
1112222发布了新的文献求助10
4秒前
胡大嘴先生完成签到,获得积分10
4秒前
Mississippiecho完成签到,获得积分0
4秒前
研友_ZG4ml8发布了新的文献求助10
5秒前
进步完成签到,获得积分10
5秒前
Zz完成签到,获得积分10
5秒前
azzzp给azzzp的求助进行了留言
5秒前
颜三路吴彦祖完成签到 ,获得积分10
6秒前
甜甜奎发布了新的文献求助10
6秒前
霸气的半邪完成签到,获得积分10
6秒前
龘靉完成签到,获得积分10
6秒前
Lsy完成签到,获得积分10
6秒前
6秒前
JamesPei的应助被小太阳采纳,获得10
7秒前
李子完成签到,获得积分10
7秒前
1111完成签到,获得积分10
7秒前
ybyytgq发布了新的文献求助10
7秒前
小丸子完成签到,获得积分10
8秒前
joy完成签到,获得积分0
8秒前
Zzzzzzz发布了新的文献求助10
9秒前
9秒前
9秒前
还想长高完成签到 ,获得积分10
9秒前
太阳雨完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180146
求助须知:如何正确求助?哪些是违规求助? 9570319
关于积分的说明 21809739
捐赠科研通 7776294
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039